NCT01964131 - BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Gastric UlcerDuodenal UlcerAnastomotic UlcerReflux EsophagitisEtc.

Interventions

DRUG

D961H sachet 20 mg

"Each subject will be randomised evenly to one of Treatment: A--\>B (Sequence 1) or Treatment: B--\>A (Sequence 2).~Treatment A: D961H sachet 20 mg Treatment B: D961H HPMC capsule 20 mg"

DRUG

D961H HPMC capsule 20 mg

"Each subject will be randomised evenly to one of Treatment: A--\>B (Sequence 1) or Treatment: B--\>A (Sequence 2). Treatment A: D961H sachet 20 mg Treatment B: D961H HPMC capsule 20 mg"

Trial Locations (2)

812-0025

Hakata Clinic Medical Co. LTA, Fukuoka

Unknown

Research Site, Fukuoka